Variant report

Variant	esv3345774
Chromosome Location	chr5:15499527-15501975
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:261)
CpG islands
(count:488)
Chromatin interactive
region (count:0)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:261 , 50 per page) page: 1 2 3 4 5 6

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr5:15500629-15500915	H1-hESC	embryonic stem cell:	n/a	n/a
2	CREB1	chr5:15500025-15500418	A549	lung:	n/a	n/a
3	CTBP2	chr5:15500015-15501869	H1-hESC	embryonic stem cell:	n/a	n/a
4	CTCF	chr5:15500120-15500270	HRPEpiC	eye:	n/a	n/a
5	CTCF	chr5:15500040-15500190	HepG2	liver:	n/a	n/a
6	CTCF	chr5:15501600-15501750	AG09309	skin:	n/a	n/a
7	CTCF	chr5:15501260-15501410	RPTEC	kidney:	n/a	n/a
8	CTCF	chr5:15501660-15501810	AoAF	blood vessel:	n/a	n/a
9	CTCF	chr5:15499920-15500070	HFF-Myc	foreskin:	n/a	n/a
10	CTCF	chr5:15501720-15501870	NHLF	lung:	n/a	n/a
11	CTCF	chr5:15501640-15501790	HRPEpiC	eye:	n/a	n/a
12	CTCF	chr5:15500180-15500285	A549	lung:	n/a	n/a
13	CTCF	chr5:15501580-15501730	GM12873	blood:	n/a	n/a
14	CTCF	chr5:15501680-15501830	HUVEC	blood vessel:	n/a	n/a
15	CTCF	chr5:15501640-15501790	HEK293	kidney:	n/a	n/a
16	CTCF	chr5:15501640-15501790	HBMEC	blood vessel:	n/a	n/a
17	CTCF	chr5:15501680-15501830	A549	lung:	n/a	n/a
18	CTCF	chr5:15500140-15500290	HBMEC	blood vessel:	n/a	n/a
19	CTCF	chr5:15500180-15500330	SAEC	small airway:	n/a	n/a
20	CTCF	chr5:15501640-15501790	HEEpiC	esophagus:	n/a	n/a
21	CTCF	chr5:15500140-15500290	AG04450	lung:	n/a	n/a
22	CTCF	chr5:15501640-15501790	NHDF-neo	bronchial:	n/a	n/a
23	CTCF	chr5:15500217-15500261	H1-hESC	embryonic stem cell:	n/a	n/a
24	CTCF	chr5:15500100-15500250	HPAF	blood vessel:	n/a	n/a
25	CTCF	chr5:15501600-15501750	HRPEpiC	eye:	n/a	n/a
26	CTCF	chr5:15501660-15501810	BJ	skin:	n/a	n/a
27	CTCF	chr5:15501660-15501810	HCM	heart:	n/a	n/a
28	CTCF	chr5:15501600-15501750	HPF	lung:	n/a	n/a
29	CTCF	chr5:15500212-15500248	Kidney_OC	kidney:	n/a	n/a
30	CTCF	chr5:15500072-15500295	SK-N-SH_RA	brain:	n/a	n/a
31	CTCF	chr5:15500100-15500250	HCM	heart:	n/a	n/a
32	CTCF	chr5:15500180-15500330	HRPEpiC	eye:	n/a	n/a
33	CTCF	chr5:15501280-15501430	AG04449	skin:	n/a	n/a
34	CTCF	chr5:15500180-15500330	HFF-Myc	foreskin:	n/a	n/a
35	CTCF	chr5:15501640-15501790	AG04450	lung:	n/a	n/a
36	CTCF	chr5:15501600-15501750	WERI-Rb-1	eye:	n/a	n/a
37	CTCF	chr5:15500166-15500303	Fibrobl	skin:	n/a	n/a
38	CTCF	chr5:15500160-15500310	NHDF-neo	bronchial:	n/a	n/a
39	CTCF	chr5:15500760-15500910	HUVEC	blood vessel:	n/a	n/a
40	CTCF	chr5:15500140-15500290	BE2_C	brain:	n/a	n/a
41	CTCF	chr5:15500520-15500670	AG04449	skin:	n/a	chr5:15500594-15500612 chr5:15500585-15500594 chr5:15500569-15500582
42	CTCF	chr5:15500157-15500305	ProgFib	skin:	n/a	n/a
43	CTCF	chr5:15500260-15500410	HFF	foreskin:	n/a	n/a
44	CTCF	chr5:15500551-15500641	Fibrobl	skin:	n/a	chr5:15500594-15500612 chr5:15500585-15500594 chr5:15500569-15500582
45	CTCF	chr5:15501660-15501810	AG10803	skin:	n/a	n/a
46	CTCF	chr5:15501200-15501350	WERI-Rb-1	eye:	n/a	n/a
47	CTCF	chr5:15501640-15501790	AG10803	skin:	n/a	n/a
48	CTCF	chr5:15501660-15501810	HAc	cerebellar:	n/a	n/a
49	CTCF	chr5:15501560-15501710	HCM	heart:	n/a	n/a
50	CTCF	chr5:15499941-15500760	IMR90	lung:	n/a	chr5:15500594-15500612 chr5:15500585-15500594 chr5:15500569-15500582

(count:488 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr5:15500833-15500883	PFSK-1	brain:	n/a
2	chr5:15500913-15500963	GM12891	blood:	n/a
3	chr5:15500913-15500963	AG04450	lung:	fetal
4	chr5:15500249-15500299	HRCEpiC	kidney:	n/a
5	chr5:15500270-15500320	GM12892	blood:	n/a
6	chr5:15500077-15500127	HCM	heart:	n/a
7	chr5:15499895-15499945	T-47D	breast:	n/a
8	chr5:15500913-15500963	HMEC	breast:	n/a
9	chr5:15500833-15500883	SK-N-MC	brain:	n/a
10	chr5:15500714-15500764	H1-hESC	embryonic stem cell:	embryo
11	chr5:15501678-15501728	AoSMC	blood vessel:	n/a
12	chr5:15500913-15500963	U87	brain:	n/a
13	chr5:15500913-15500963	Jurkat	blood:	n/a
14	chr5:15500913-15500963	LNCaP	prostate:	n/a
15	chr5:15501678-15501728	A549	lung:	n/a
16	chr5:15500714-15500764	SK-N-SH_RA	brain:	n/a
17	chr5:15500833-15500883	HRE	kidney:	n/a
18	chr5:15500714-15500764	CMK	blood:	n/a
19	chr5:15501678-15501728	AG09309	skin:	n/a
20	chr5:15500077-15500127	HepG2	liver:	n/a
21	chr5:15500249-15500299	HUVEC	blood vessel:	n/a
22	chr5:15500714-15500764	HEK293	kidney:	embryo
23	chr5:15500714-15500764	GM19239	blood:	n/a
24	chr5:15500913-15500963	HNPCEpiC	eye:	n/a
25	chr5:15501678-15501728	HNPCEpiC	eye:	n/a
26	chr5:15500833-15500883	PrEC	prostate:	n/a
27	chr5:15499895-15499945	AG09309	skin:	n/a
28	chr5:15500833-15500883	NHDF-neo	bronchial:	n/a
29	chr5:15500077-15500127	HRPEpiC	eye:	n/a
30	chr5:15500913-15500963	SK-N-SH_RA	brain:	n/a
31	chr5:15500249-15500299	HCPEpiC	choroid plexus:	n/a
32	chr5:15500249-15500299	PrEC	prostate:	n/a
33	chr5:15500249-15500299	SKMC	muscle:	n/a
34	chr5:15500714-15500764	A549	lung:	n/a
35	chr5:15500913-15500963	PrEC	prostate:	n/a
36	chr5:15500714-15500764	SK-N-SH	brain:	n/a
37	chr5:15500270-15500320	PFSK-1	brain:	n/a
38	chr5:15500714-15500764	LNCaP	prostate:	n/a
39	chr5:15500833-15500883	ovcar-3	ovarian:	n/a
40	chr5:15500913-15500963	HCT-116	colon:	n/a
41	chr5:15500714-15500764	K562	blood:	n/a
42	chr5:15500077-15500127	Caco-2	colon:	n/a
43	chr5:15500249-15500299	HCT-116	colon:	n/a
44	chr5:15499895-15499945	SK-N-MC	brain:	n/a
45	chr5:15500270-15500320	SKMC	muscle:	n/a
46	chr5:15499895-15499945	SAEC	small airway:	n/a
47	chr5:15500833-15500883	SAEC	small airway:	n/a
48	chr5:15500913-15500963	SK-N-SH	brain:	n/a
49	chr5:15501678-15501728	HMEC	breast:	n/a
50	chr5:15500249-15500299	Jurkat	blood:	n/a

No data

Variant related genes	Relation type
FBXL7	TF binding region
FBXL7	CpG island

Extended variants
information (count: 102 )
Associated
traits (count: 93 )

Variant overlapped rSNPs/rCNVs (count:102 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs143815957	chr5:15499588-15499589	Active TSS Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
2	rs558430769	chr5:15499590-15499591	Active TSS Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs147255586	chr5:15499595-15499596	Active TSS Weak transcription Flanking Active TSS Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs77088637	chr5:15499642-15499643	Active TSS Weak transcription Flanking Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs184033115	chr5:15499689-15499690	Active TSS Weak transcription Flanking Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs538458659	chr5:15499695-15499696	Active TSS Weak transcription Flanking Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs574434293	chr5:15499712-15499713	Active TSS Weak transcription Flanking Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs367952946	chr5:15499714-15499715	Active TSS Weak transcription Flanking Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs570068879	chr5:15499768-15499769	Active TSS Weak transcription Flanking Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs537539150	chr5:15499826-15499827	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs375193675	chr5:15499837-15499838	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs544433355	chr5:15499839-15499840	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs187823430	chr5:15499854-15499855	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs541788815	chr5:15499855-15499856	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs553715369	chr5:15499880-15499881	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs556727649	chr5:15499905-15499906	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
17	rs578008532	chr5:15499975-15499976	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs545509698	chr5:15499987-15499988	Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs369476340	chr5:15500079-15500080	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
20	rs578159702	chr5:15500089-15500090	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
21	rs76211078	chr5:15500095-15500096	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
22	rs374972878	chr5:15500124-15500125	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
23	rs560243142	chr5:15500141-15500142	Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs192506210	chr5:15500207-15500208	Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs542684816	chr5:15500209-15500210	Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs373409040	chr5:15500213-15500214	Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs528066589	chr5:15500241-15500242	Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs377379955	chr5:15500249-15500250	Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
29	rs546148027	chr5:15500260-15500261	Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
30	rs372983518	chr5:15500263-15500264	Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
31	rs375952615	chr5:15500271-15500272	Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
32	rs532402258	chr5:15500279-15500280	Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
33	rs550537153	chr5:15500290-15500291	Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
34	rs569013257	chr5:15500302-15500303	Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
35	rs112289589	chr5:15500307-15500308	Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
36	rs549492404	chr5:15500323-15500324	Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs139767597	chr5:15500337-15500338	Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs535016943	chr5:15500343-15500344	Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs553373000	chr5:15500389-15500390	Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
40	rs578197287	chr5:15500427-15500428	Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
41	rs370614214	chr5:15500439-15500440	Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
42	rs372622055	chr5:15500524-15500525	Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
43	rs370307411	chr5:15500574-15500575	Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs575790249	chr5:15500577-15500578	Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
45	rs542353119	chr5:15500614-15500615	Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
46	rs560658914	chr5:15500649-15500650	Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
47	rs542654103	chr5:15500657-15500658	Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
48	rs540091616	chr5:15500670-15500671	Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
49	rs572576226	chr5:15500673-15500674	Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
50	rs539858244	chr5:15500678-15500679	Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:93)

Disease	PMID	Source
Lung cancer	19547694	CNVD
Cri-du chat syndrome	22283845	CNVD
Disorders of sex development	21048976	CNVD
Non-small cell lung cancer	20864512	CNVD
Cancer	21183584	CNVD
Cervical squamous cell carcinoma	21590768	CNVD
Honadal dysgenesis	21048976	CNVD
Cancer	16751803	CNVD
Breast cancer	17133270	CNVD
Hepatocellular carcinoma	22174799	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Salivary gland tumor	18059337	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Kartagener syndrome	16639409	CNVD
Medulloblastoma	21979893	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Medulloblastoma	16783165	CNVD
Thyroid cancer	19087340	CNVD
Liposarcoma	21253554	CNVD
Pancreatic endocrine tumor	17639061	CNVD
Cervical Cancer	21857958	CNVD
Cervical cancer	21062161	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	19960244	CNVD
Oral cancer	21386901	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Ewing''s sarcoma	17952124	CNVD
Malignant mesothelioma	18160781	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Cervical cancer	18559093	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Metanephric adenoma	20802469	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Phyllodes tumor	17334353	CNVD
Malaria	21533027	CNVD
Renal cell carcinoma	19461508	CNVD
Colorectal cancer	21645411	CNVD
Gastric cancer	22152101	CNVD
Oesophago-gastric ulcer	22152101	CNVD
Ovarian cancer	21781307	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Cancer	20164919	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Multiple myeloma	17550852	CNVD
prenatal diagnosis	22389664	CNVD
Bladder cancer	21909424	CNVD
DNA damage stimulus	22844521	CNVD
DNA repair	22844521	CNVD
Breast cancer	21785460	CNVD
Spinal muscular atrophy	22422766	CNVD
Spinal muscular atrophy	22558076	CNVD
Spinal muscular atrophy	21320981	CNVD
Spinal muscular atrophy	21762474	CNVD
Breast cancer	21858162	CNVD
Prostate cancer	18632612	CNVD
Esophageal adenocarcinoma	19417022	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Gastrointestinal stromal cancer	20818650	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	16608533	CNVD
Anaplastic large cell lymphoma	18179710	CNVD
Autism	22495311	CNVD
Melanoma	18172304	CNVD
Non-syndromic sensorineural hearing loss	20606397	CNVD
Intellectual disability	22102821	CNVD
Ovarian clear cell carcinoma	19293255	CNVD
Breast cancer	21364760	CNVD
Pleomorphic liposarcoma	18784837	CNVD
Williams Syndrome	20824207	CNVD
Urothelial carcinoma	21177765	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Acute lymphoblastic leukemia	17640729	CNVD
Myoepithelioma	18604193	CNVD
Lung cancer	16740712	CNVD
Myelofibrosis	22110671	CNVD
Glioblastoma multiforme	22286061	CNVD
Schizophrenia	23813976	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:269 , 50 per page) page: 1 2 3 4 5 6

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr5:15495400-15499600	Weak transcription	Fetal Muscle Leg	muscle
2	chr5:15495800-15499600	Weak transcription	Ovary	ovary
3	chr5:15496600-15499800	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
4	chr5:15497400-15499600	Weak transcription	H9 Cell Line	embryonic stem cell
5	chr5:15498600-15499600	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
6	chr5:15499200-15499600	Flanking Active TSS	iPS-20b Cell Line	embryonic stem cell
7	chr5:15499200-15499600	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
8	chr5:15499200-15499600	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
9	chr5:15499200-15499600	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
10	chr5:15499200-15499600	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
11	chr5:15499200-15499600	Enhancers	Brain Cingulate Gyrus	brain
12	chr5:15499200-15499600	Enhancers	Placenta Amnion	Placenta Amnion
13	chr5:15499200-15499800	Bivalent Enhancer	Fetal Brain Male	brain
14	chr5:15499200-15500000	Flanking Active TSS	Dnd41	blood
15	chr5:15499400-15499600	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
16	chr5:15499400-15499600	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
17	chr5:15499400-15499600	Flanking Active TSS	HUES6 Cell Line	embryonic stem cell
18	chr5:15499400-15499600	Flanking Active TSS	iPS-15b Cell Line	embryonic stem cell
19	chr5:15499400-15499600	Enhancers	Breast Myoepithelial Primary Cells	Breast
20	chr5:15499400-15499600	Enhancers	Muscle Satellite Cultured Cells	--
21	chr5:15499400-15499600	Enhancers	Cortex derived primary cultured neurospheres	brain
22	chr5:15499400-15499600	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
23	chr5:15499400-15499600	Flanking Active TSS	Adipose Nuclei	Adipose
24	chr5:15499400-15499600	Enhancers	Brain Angular Gyrus	brain
25	chr5:15499400-15499600	Enhancers	Brain Germinal Matrix	brain
26	chr5:15499400-15499600	Enhancers	Brain Dorsolateral Prefrontal Cortex	brain
27	chr5:15499400-15499600	Active TSS	Fetal Brain Female	brain
28	chr5:15499400-15499600	Flanking Active TSS	Fetal Heart	heart
29	chr5:15499400-15499600	Flanking Active TSS	Fetal Kidney	kidney
30	chr5:15499400-15499600	Enhancers	Pancreatic Islets	Pancreatic Islet
31	chr5:15499400-15499600	Bivalent Enhancer	Fetal Lung	lung
32	chr5:15499400-15499600	Enhancers	Fetal Stomach	stomach
33	chr5:15499400-15499600	Enhancers	Rectal Smooth Muscle	rectum
34	chr5:15499400-15499600	Bivalent Enhancer	Skeletal Muscle Male	skeletal muscle
35	chr5:15499400-15499600	Flanking Active TSS	Stomach Smooth Muscle	stomach
36	chr5:15499400-15499600	Bivalent Enhancer	A549	lung
37	chr5:15499400-15499600	Enhancers	HSMM	muscle
38	chr5:15499400-15499600	Enhancers	NH-A	brain
39	chr5:15499400-15499800	Flanking Active TSS	iPS-18 Cell Line	embryonic stem cell
40	chr5:15499400-15499800	Flanking Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
41	chr5:15499400-15500000	Flanking Active TSS	H9 Derived Neuron Cultured Cells	ES cell derived
42	chr5:15499400-15500000	Flanking Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
43	chr5:15499400-15500000	Flanking Active TSS	HUES48 Cell Line	embryonic stem cell
44	chr5:15499400-15500000	Flanking Active TSS	HUES64 Cell Line	embryonic stem cell
45	chr5:15499400-15500000	Flanking Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
46	chr5:15499400-15500000	Flanking Active TSS	Foreskin Keratinocyte Primary Cells skin03	Skin
47	chr5:15499400-15500000	Flanking Active TSS	Osteobl	bone
48	chr5:15499400-15500200	Flanking Active TSS	HUVEC	blood vessel
49	chr5:15499400-15500600	Active TSS	Brain Inferior Temporal Lobe	brain
50	chr5:15499400-15500800	Active TSS	H1 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links